Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Chemo-induced heart damage is a common side effect of adriamycin and cytotoxan, two of my chemotherapy drugs. I developed the late-stage side effect of permanent or chronic atrial fibrillation (A Fib) in 11/10. I wish I had known about CoQ10 at the time of my aggressive chemotherapy…
My symptoms include shortness of breath and I get tired and nap most days. My real fear is not knowing what will happen to me/my heart as I age. In other words, I have the daily reminder that my heart doesn’t work well and may be weakening.
I was diagnosed with multiple myeloma in 2/94 at the age of 34. I underwent aggressive therapy beginning with surgery to remove the lesion followed by induction therapy, and an autologous stem cell transplant in 12/95.
I have supplemented with Coq10 Doctor’s Best High Absorption CoQ10 with BioPerine, Gluten Free, Naturally Fermented, Heart Health, Energy Production since 2011.
If you are a newly diagnosed cancer patient and if you have not yet begun active therapy the key issue to consider is:
Have you been diagnosed with cancer? What type? What stage? If you would like to ask questions about your treatment or Coq10 supplementation scroll down the page post a question and I will reply ASAP.
“Myocardial deficiency of CoQ10 has been demonstrated in endomyocardial biopsy samples from patients with cardiomyopathy, and deficiency of CoQ10 correlated with the severity of disease, suggesting that therapy with CoQ10 can result in improving the quality of life of cardiac patients by enhancing myocardial contractility [Folkers et al., 1985b]…”
“The aim of this systematic review was to summarize and evaluate the evidence available for oral supplementation with coenzyme Q10 (CoQ10) to improve the tolerability of cancer treatments…
” However, 3-20% of breast cancer patients develop chronic cardiomyopathic changes and congestive heart failure due to doxorubicin therapy. Doxorubicin-induced cardiotoxicity is thought to be due to increased generation of reactive oxygen species (ROS) within cardiac myocyte mitochondria. Coenzyme Q10 (CoQ10) is a lipid-soluble antioxidant that may protect against mitochondrial ROS, and thus prevent doxorubicin-induced cardiotoxicity…”